ERDERA at the Chan Zuckerberg Initiative workshop on systematically characterising rare diseases

ERDERA at the Chan Zuckerberg Initiative workshop on systematically characterising rare diseases

ERDERA coordination participated in the Chan Zuckerberg Initiative’s “Building a Roadmap to Systematically Characterize Rare Diseases” workshop, taking place March 24–26 at CZI Headquarters in Redwood City, California.  

This convening brought together leaders from across academia, industry, and patient advocacy to co‑create a strategic framework for defining essential parameters of rare disease characterisation, refining assays and technologies, mapping shared biological mechanisms, and developing an actionable pilot programme.  

ERDERA coordination was represented by Yanis Mimouni, ERDERA Assistant Coordinator, who contributed with the programmes perspective and expertise in fostering collaboration and driving progress towards scalable, cross‑organisation initiatives that advance and accelerate rare disease research. 

The workshop was organised by the Chan Zuckerberg Initiative (CZI), a philanthropic organisation founded by Mark Zuckerberg and Priscilla Chan dedicated to addressing some of society’s most significant challenges, including disease eradication, educational improvement, and meeting the needs of local communities. 

News & Updates

You might also be interested in

Ana Rath, Data Services Co-Lead in ERDERA, explains how the consortium is helping researchers and data holders make rare disease data more findable, interoperable and reusable while protecting privacy and keeping data holders in control.
ERDERA contributed to the first Journée nationale FrBioNet, bringing a European rare disease perspective to discussions with the French biobanking community.
September 16 @ 11:00 am - 12:30 pm
A webinar offering practical guidance on how to pitch to investors, aimed at researchers, clinicians, academics and SMEs working on rare disease projects.
Held in Riga on 9–10 June, the workshop brought National Mirror Group experts, researchers, clinicians and policymakers together to exchange practical lessons on how national rare disease registries can better support research and alignment across countries.